The prevalence of pediatric nonalcoholic fatty liver disease is increasing, but early stages are reversible, so it’s important for providers to understand which kids to screen and what their test results signify. Reporting on her recent study, pediatric gastroenterologist Namrata Patel-Sanchez, MD, MPH, clarifies the connections with conditions including polycystic ovary disease and type 2 diabetes, and with factors such as ethnicity and lifestyle. She also gives the evidence on which treatments work.
- Define and evaluate a patient for Non-Alcoholic Fatty Liver Disease (NAFLD) using NASPGHAN guidelines.
- Identify which patients to screen for NAFLD.
- List the different types of observational study design.
- Identify which patients with PCOS to screen for NAFLD.